Better Therapeutics, Inc.

The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.

Good afternoon, and welcome to the Better Therapeutics Third Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. Please be advised that today's conference is being recorded. I would now like to turn the call over to Mark Heinen, Chief Financial Officer. Please begin.

Thank you, operator. Good afternoon, everyone, and welcome to the Better Therapeutics conference call to discuss our third quarter 2022 financial results and business update. Our press release was issued this afternoon and can be found in the investors section of our corporate website, bettertx.com. Joining me on the call today is Frank Karba, our president and chief executive officer, Dr. Mark Berman, our chief medical officer, and Diane Gomez-Venez, our Chief Commercial Officer. During today's call, we will provide a business and financial overview of the third quarter of 2022 and provide our outlook for the fourth quarter of 2022 and beyond. A Q&A session will follow our prepared remarks. Before we begin, I would like to remind everyone that any statements we make or information presented on this call that are not historical facts are forward-looking statements that are based on our current beliefs, plans, and expectations and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual events and results may differ materially from those expressed or implied by any forward-looking statements due to various risks, uncertainties, and other factors, including those described in the risk factor section of our most recent SEC filings and any other future filings we may with the SEC. You are cautioned not to place any undue reliance on these forward-looking statements. These forward-looking statements represent our views as of this call and should not be relied upon as representing our views as of any subsequent date. We undertake no obligation to publicly update these statements. With that, I'll pass the call over to Frank Carva. Frank?